IKK/IκB inhibitor BMS-345541, Purity ≥98%

Cat. No.: X23-10-ZQ762

IKK/IκB inhibitor BMS-345541, Purity ≥98%

Synonym: 445430-58-0; BMS-345541; BMS-345541 free base; BMS345541; N1-(1,8-Dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine; IKK Inhibitor III, BMS-345541; IKK Inhibitor III; IKK/IκB inhibitor

  • CAS Number: 445430-58-0
  • Compound CID: 9813758
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BMS-345541, soluble in DMSO and insoluble in ethanol and water, modulates IKK-IκB signaling pathway, which plays a key role in inflammation and immune responses. It targets IKK1 and IKK2.
Molecular Weight
255.32
Molecular Formula
C14H17N5
Targets
IKK1: 4 μM; IKK2: 0.3 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 8 mg/mL (31.32 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
BMS-345541 can be explored as a selective IκB kinase inhibitor to understand its role in modulating NF-κB signaling in inflammatory and autoimmune disease research.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0